Page last updated: 2024-08-25

chitosan and efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination

chitosan has been researched along with efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdoli, A; Ardestani, MS; Ghanbari, M; Haj, MS; Khansarinejad, B; Mondanizadeh, M; Salimi-Asl, M; Shohani, S; Zabihollahi, R	1

Other Studies

1 other study(ies) available for chitosan and efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination

Article	Year
Trimethyl Chitosan Improves Anti-HIV Effects of Atripla as a New Nanoformulated Drug. Current HIV research, 2017, Volume: 15, Issue:1 Topics: Anti-HIV Agents; Cell Survival; Chitosan; Drug Carriers; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Enzyme-Linked Immunosorbent Assay; HEK293 Cells; HIV; HIV Core Protein p24; Humans; Microscopy, Atomic Force; Nanoparticles; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Virus Replication	2017

Article

Year

Trimethyl Chitosan Improves Anti-HIV Effects of Atripla as a New Nanoformulated Drug.

Current HIV research, 2017, Volume: 15, Issue:1

Topics: Anti-HIV Agents; Cell Survival; Chitosan; Drug Carriers; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Enzyme-Linked Immunosorbent Assay; HEK293 Cells; HIV; HIV Core Protein p24; Humans; Microscopy, Atomic Force; Nanoparticles; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Virus Replication

2017